Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endoscopic botulinum toxin injection for hypercontractile esophagus
2013-001145-14Phase 2Active
- Sponsor
- Hospices Civils de Lyon
- Start
- Sep 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of botulinum toxin type A in Hypercontractile Esophagus (HE) and Nutcracker esophagus (NE) (2 arms), sponsored by Hospices Civils de Lyon. Primary endpoint: Clinical symptom improvement at 3 months. Started Sep 2015; status: active.
02
Drugs
botulinum toxin type A
03
Conditions
Hypercontractile Esophagus (HE)Nutcracker esophagus (NE)
Beyond the preview
Go deeper on 2013-001145-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001145-14.